End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% | -.--% | -.--% |
23/04 | PainChek Secures AU$1,210,000 R&D Tax Incentive | MT |
14/03 | PainChek Establishes Reseller Agreement with UK-Based Nourish Care; Shares Rise 3% | MT |
Sales 2022 | 994K 649K 54.15M | Sales 2023 | 1.96M 1.28M 107M | Capitalization | 32.45M 21.2M 1.77B |
---|---|---|---|---|---|
Net income 2022 | -5M -3.27M -272M | Net income 2023 | -7M -4.57M -381M | EV / Sales 2022 | 28.7 x |
Net cash position 2022 | 6.14M 4.01M 335M | Net cash position 2023 | 2.51M 1.64M 137M | EV / Sales 2023 | 15.3 x |
P/E ratio 2022 |
-5.52
x | P/E ratio 2023 |
-4.26
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.56% |
Managers | Title | Age | Since |
---|---|---|---|
Philip Daffas
CEO | Chief Executive Officer | - | 30/16/30 |
Iain McAdam
DFI | Director of Finance/CFO | - | 22/21/22 |
Andrew Hoggan
COO | Chief Operating Officer | - | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Murray
CHM | Chairman | 65 | 30/16/30 |
Ross Harricks
BRD | Director/Board Member | 79 | 30/16/30 |
Adam Davey
BRD | Director/Board Member | - | 30/14/30 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.17% | 322B | |
+24.75% | 216B | |
+2.41% | 149B | |
+10.65% | 56.27B | |
+8.71% | 32.13B | |
-4.57% | 27.45B | |
+103.03% | 22.62B | |
+20.22% | 19.55B | |
+13.06% | 14.69B |
- Stock Market
- Equities
- PCK Stock
- PCK Stock